Abstract: To automate time series forecasting machine learning pipeline generation, a data allocation size of time series data may be determined based on one or more characteristics of a time series data set. The time series data may be allocated for use by candidate machine learning pipelines based on the data allocation size. Features for the time series data may be determined and cached by the candidate machine learning pipelines. Predictions of each of the candidate machine learning pipelines using at least the one or more features may be evaluated. A ranked list of machine learning pipelines may be automatically generated from the candidate machine learning pipelines for time series forecasting based upon evaluating predictions of each of the one or more candidate machine learning pipelines.

Abstract: Method for providing a natural colour and optical depth to a dental object comprising the steps: providing a framework of the dental object, taking an object colour picture of an adjacent dental object or reference dental object, and uploading the object colour picture into a computing device, calibrating and adjusting the uploaded object colour picture into a target object colour picture in a computing device, (pre)determining the thickness profile of the enamel material to be applied on the framework, correcting in a computing device of the digital picture elements of the target object colour picture for the thickness profile of the enamel material to be applied on the position of the digital picture elements and providing a print colour picture of the corrected digital picture elements, printing the print colour picture as a print layer on the framework, applying the enamel material in the predetermined profile-thickness upon the print layer upon the framework.

Abstract: Methods, systems, and apparatus, including computer programs encoded on computer storage media for performing preflight checks of a distributed computing system, are described. In one aspect, a method includes assigning a computing workload to a first subset of hardware accelerator machines each having one or more hardware accelerators. A preflight check on the first subset is performed before performing the computing workload to verify the functionality of each machine in the first subset. For each hardware accelerator machine of the first subset, a program code package is installed, including a task action based at least in part on characteristics of the computing workload. The task action including a sequence of operations is performed on the hardware accelerator machine to determine whether the task action fails. Whenever the task action fails, the computing workload is re-assigned to a second subset of hardware accelerator machines different from the first subset.

Abstract: Methods and compositions for restoring myelin levels in conditions associated with myelin degeneration, for example, an aging and aging-related neurodegenerative and/or neuroinflammatory disease or a myelopathy associated with postoperative recovery. The compositions used in the methods include blood plasma and blood plasma fractions derived from blood plasma with efficacy in restoring myelin levels and/or improving nerve conductance.

Abstract: Method for providing a natural colour and optical depth to a dental object comprising the steps: providing a framework of the dental object, taking an object colour picture of an adjacent dental object or reference dental object, and uploading the object colour picture into a computing device, calibrating and adjusting the uploaded object colour picture into a target object colour picture in a computing device, (pre)determining the thickness profile of the enamel material to be applied on the framework, correcting in a computing device of the digital picture elements of the target object colour picture for the thickness profile of the enamel material to be applied on the position of the digital picture elements and providing a print colour picture of the corrected digital picture elements, printing the print colour picture as a print layer on the framework, applying the enamel material in the predetermined profile-thickness upon the print layer upon the framework.

Abstract: Methods and compositions for treating and/or preventing aging-related conditions are described. The compositions used in the methods include fractions derived from blood plasma with efficacy in treating and/or preventing aging-related conditions such as neurocognitive disorders.

Abstract: Methods and compositions for treating and/or preventing aging-related conditions are described. The compositions used in the methods include fractions derived from blood plasma with efficacy in treating and/or preventing aging-related conditions such as neurocognitive disorders.

Abstract: Methods and compositions for treating and/or preventing aging-related conditions are described. The compositions used in the methods include fractions derived from blood plasma with efficacy in treating and/or preventing aging-related conditions such as neurocognitive disorders.

Abstract: Methods and compositions for treating and/or preventing aging-related conditions are described. The compositions used in the methods include fractions derived from blood plasma with efficacy in treating and/or preventing aging-related conditions such as neurocognitive disorders.

Abstract: The present disclosure relates to a method of epoxidizing an olefin to form an epoxide, the method comprising contacting an alkene(C?12) or aralkene(C?12) with a titanium silica catalyst, a peroxide, a buffer, and one or more organic solvents in a reaction mixture, wherein the one or more organic solvents comprise a first organic solvent selected from: R1—OH??(I), R2—CN??(II), R3—C(O)—R4??(III) or R5—O—R6??(IV) wherein: R1 is alkyl(C?12), aryl(C?12), aralkyl(C?12) or a substituted version of any of these groups; R2 is alkyl(C?12), aryl(C?12), aralkyl(C?12) or a substituted version of any of these groups; R3 is hydrogen, alkyl(C?6) or substituted alkyl(C?6); and R4, R5, and R6 are each independently selected from alkyl(C?12), aryl(C?12), aralkyl(C?12) or a substituted version of any of these groups, or are taken together are alkoxydiyl(C?12), alkanediyl(C?12), substituted alkoxydiyl(C?12) or substituted alkanediyl(C?12).

Abstract: The present disclosure relates to a method of preparing propylene oxide comprising the steps: (a) oxidizing alpha-methylbenzyl alcohol with air to form a first reaction mixture comprising hydrogen peroxide and acetophenone; (b) reacting propylene with the first reaction mixture in the presence of a catalyst to form a second reaction mixture comprising propylene oxide; (c) separating the propylene oxide from the second reaction mixture to form a third reaction mixture; (d) heating the third reaction mixture to decompose hydrogen peroxide, whereby a fourth reaction mixture is formed; (e) hydrogenating the acetophenone in the fourth reaction mixture with hydrogen to form a fifth reaction mixture comprising alpha-methylbenzyl alcohol; and (f) separating alpha-methylbenzyl alcohol from the fifth reaction mixture and returning the methyl benzyl alcohol to step (a).

Abstract: The present disclosure generally relates to a silica-titanium catalyst prepared by first reacting a solid support with a metal alkoxide and then depositing titanium onto the solid support for the epoxidation of alkenes and aralkenes and a method of preparing the catalyst thereof. In some embodiments, the present disclosure relates to methods of using the catalyst described herein for the production of epoxides.

Abstract: The present disclosure relates to a method of preparing propylene oxide comprising the steps: (a) oxidizing alpha-methylbenzyl alcohol with air to form a first reaction mixture comprising hydrogen peroxide and acetophenone; (b) reacting propylene with the first reaction mixture in the presence of a catalyst to form a second reaction mixture comprising propylene oxide; (c) separating the propylene oxide from the second reaction mixture to form a third reaction mixture; (d) heating the third reaction mixture to decompose hydrogen peroxide, whereby a fourth reaction mixture is formed; (e) hydrogenating the acetophenone in the fourth reaction mixture with hydrogen to form a fifth reaction mixture comprising alpha-methylbenzyl alcohol; and (f) separating alpha-methylbenzyl alcohol from the fifth reaction mixture and returning the methyl benzyl alcohol to step (a).

Abstract: The present disclosure relates to a method of epoxidizing an olefin to form an epoxide, the method comprising contacting an alkene(C?12) or aralkene(C?12) with a titanium silica catalyst, a peroxide, a buffer, and one or more organic solvents in a reaction mixture, wherein the one or more organic solvents comprise a first organic solvent selected from: R1—OH??(I), R2—CN??(II), R3—C(O)—R4??(III) or R5—O—R6??(IV) wherein: R1 is alkyl(C?12), aryl(C?12), aralkyl(C?12) or a substituted version of any of these groups; R2 is alkyl(C?12), aryl(C?12), aralkyl(C?12) or a substituted version of any of these groups; R3 is hydrogen, alkyl(C?6) or substituted alkyl(C?6); and R4, R5, and R6 are each independently selected from alkyl(C?12), aryl(C?12), aralkyl(C?12) or a substituted version of any of these groups, or are taken together are alkoxydiyl(C?12), alkanediyl(C?12), substituted alkoxydiyl(C?12) or substituted alkanediyl(C?12).

Abstract: The present disclosure generally relates to a silica-titanium catalyst prepared by first reacting a solid support with a metal alkoxide and then depositing titanium onto the solid support for the epoxidation of alkenes and aralkenes and a method of preparing the catalyst thereof. In some embodiments, the present disclosure relates to methods of using the catalyst described herein for the production of epoxides.

Abstract: The present disclosure provides methods of treating a tauopathy, involving administering an anti-Tau antibody. The present disclosure also provides anti-Tau antibodies, and formulations comprising same, for use in the methods.

Abstract: The present disclosure provides methods of treating a tauopathy, involving administering an anti-Tau antibody. The present disclosure also provides anti-Tau antibodies, and formulations comprising same, for use in the methods.

Abstract: The present disclosure provides methods of treating a tauopathy, involving administering an anti-Tau antibody. The present disclosure also provides anti-Tau antibodies, and formulations comprising same, for use in the methods.

Abstract: The present disclosure provides methods of treating a tauopathy, involving administering an anti-Tau antibody. The present disclosure also provides anti-Tau antibodies, and formulations comprising same, for use in the methods.

Abstract: The present disclosure provides methods of treating a tauopathy, involving administering an anti-Tau antibody. The present disclosure also provides anti-Tau antibodies, and formulations comprising same, for use in the methods.